vs
Healthpeak Properties（DOC）与MURPHY OIL CORP（MUR）财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是MURPHY OIL CORP的1.1倍（$702.9M vs $613.1M），Healthpeak Properties净利率更高（51.6% vs 1.9%，领先49.7%），Healthpeak Properties同比增速更快（-6.6% vs -8.4%），过去两年Healthpeak Properties的营收复合增速更高（0.5% vs -12.2%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
墨菲石油公司是一家美国能源企业，核心业务为油气勘探开发，总部位于得克萨斯州休斯敦，在全球能源勘探领域拥有成熟的业务布局与行业经验。
DOC vs MUR — 直观对比
营收规模更大
DOC
是对方的1.1倍
$613.1M
营收增速更快
DOC
高出1.8%
-8.4%
净利率更高
DOC
高出49.7%
1.9%
两年增速更快
DOC
近两年复合增速
-12.2%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $702.9M | $613.1M |
| 净利润 | $363.0M | $11.9M |
| 毛利率 | — | — |
| 营业利润率 | 0.7% | 9.7% |
| 净利率 | 51.6% | 1.9% |
| 营收同比 | -6.6% | -8.4% |
| 净利润同比 | 28.3% | -76.3% |
| 每股收益（稀释后） | $0.28 | $0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCMUR
| Q1 26 | $702.9M | — | ||
| Q4 25 | $719.4M | $613.1M | ||
| Q3 25 | $705.9M | $721.0M | ||
| Q2 25 | $694.3M | $683.0M | ||
| Q1 25 | $702.9M | $672.7M | ||
| Q4 24 | $698.0M | $669.6M | ||
| Q3 24 | $700.4M | $753.2M | ||
| Q2 24 | $695.5M | $801.0M |
净利润DOCMUR
| Q1 26 | $363.0M | — | ||
| Q4 25 | $114.0M | $11.9M | ||
| Q3 25 | $-117.1M | $-3.0M | ||
| Q2 25 | $31.7M | $22.3M | ||
| Q1 25 | $42.8M | $73.0M | ||
| Q4 24 | $4.5M | $50.4M | ||
| Q3 24 | $85.9M | $139.1M | ||
| Q2 24 | $146.0M | $127.7M |
毛利率DOCMUR
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 58.6% | — | ||
| Q2 25 | 60.2% | — | ||
| Q1 25 | 61.1% | — | ||
| Q4 24 | 60.3% | — | ||
| Q3 24 | 60.0% | — | ||
| Q2 24 | 60.6% | 99.6% |
营业利润率DOCMUR
| Q1 26 | 0.7% | — | ||
| Q4 25 | 17.4% | 9.7% | ||
| Q3 25 | 9.2% | 0.8% | ||
| Q2 25 | 5.7% | 13.5% | ||
| Q1 25 | 7.7% | 21.4% | ||
| Q4 24 | -2.2% | 12.7% | ||
| Q3 24 | 14.1% | 23.8% | ||
| Q2 24 | 22.3% | 23.0% |
净利率DOCMUR
| Q1 26 | 51.6% | — | ||
| Q4 25 | 73.2% | 1.9% | ||
| Q3 25 | -16.6% | -0.4% | ||
| Q2 25 | 4.6% | 3.3% | ||
| Q1 25 | 6.1% | 10.9% | ||
| Q4 24 | 0.7% | 7.5% | ||
| Q3 24 | 12.3% | 18.5% | ||
| Q2 24 | 21.0% | 15.9% |
每股收益（稀释后）DOCMUR
| Q1 26 | $0.28 | — | ||
| Q4 25 | $0.16 | $0.08 | ||
| Q3 25 | $-0.17 | $-0.02 | ||
| Q2 25 | $0.05 | $0.16 | ||
| Q1 25 | $0.06 | $0.50 | ||
| Q4 24 | $0.02 | $0.35 | ||
| Q3 24 | $0.12 | $0.93 | ||
| Q2 24 | $0.21 | $0.83 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $-1.2B | $377.2M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $7.8B | $5.1B |
| 总资产 | $21.6B | $9.8B |
| 负债/权益比越低杠杆越低 | — | 0.27× |
8季度趋势，按日历期对齐
现金及短期投资DOCMUR
| Q1 26 | $-1.2B | — | ||
| Q4 25 | $467.5M | $377.2M | ||
| Q3 25 | $91.0M | $426.0M | ||
| Q2 25 | $89.4M | $379.6M | ||
| Q1 25 | $70.6M | $392.9M | ||
| Q4 24 | $119.8M | $423.6M | ||
| Q3 24 | $180.4M | $271.2M | ||
| Q2 24 | $106.9M | $333.6M |
总债务DOCMUR
| Q1 26 | — | — | ||
| Q4 25 | $9.8B | $1.4B | ||
| Q3 25 | $9.1B | $1.4B | ||
| Q2 25 | $9.0B | $1.5B | ||
| Q1 25 | $8.9B | $1.5B | ||
| Q4 24 | $8.7B | $1.3B | ||
| Q3 24 | $8.6B | $1.3B | ||
| Q2 24 | $8.6B | $1.3B |
股东权益DOCMUR
| Q1 26 | $7.8B | — | ||
| Q4 25 | $7.5B | $5.1B | ||
| Q3 25 | $7.6B | $5.1B | ||
| Q2 25 | $7.9B | $5.2B | ||
| Q1 25 | $8.2B | $5.1B | ||
| Q4 24 | $8.4B | $5.2B | ||
| Q3 24 | $8.6B | $5.2B | ||
| Q2 24 | $8.8B | $5.3B |
总资产DOCMUR
| Q1 26 | $21.6B | — | ||
| Q4 25 | $20.3B | $9.8B | ||
| Q3 25 | $19.6B | $9.7B | ||
| Q2 25 | $19.8B | $9.8B | ||
| Q1 25 | $19.8B | $9.8B | ||
| Q4 24 | $19.9B | $9.7B | ||
| Q3 24 | $20.0B | $9.7B | ||
| Q2 24 | $20.2B | $9.9B |
负债/权益比DOCMUR
| Q1 26 | — | — | ||
| Q4 25 | 1.31× | 0.27× | ||
| Q3 25 | 1.20× | 0.28× | ||
| Q2 25 | 1.14× | 0.28× | ||
| Q1 25 | 1.08× | 0.29× | ||
| Q4 24 | 1.04× | 0.25× | ||
| Q3 24 | 1.00× | 0.24× | ||
| Q2 24 | 0.98× | 0.24× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $249.6M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 3.4% | — |
| 现金转化率经营现金流/净利润 | — | 20.92× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DOCMUR
| Q1 26 | — | — | ||
| Q4 25 | $1.3B | $249.6M | ||
| Q3 25 | $315.0M | $339.4M | ||
| Q2 25 | $363.5M | $358.1M | ||
| Q1 25 | $279.4M | $300.7M | ||
| Q4 24 | $1.1B | $433.6M | ||
| Q3 24 | $318.2M | $429.0M | ||
| Q2 24 | $316.2M | $467.7M |
自由现金流DOCMUR
| Q1 26 | — | — | ||
| Q4 25 | $357.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $333.7M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
自由现金流率DOCMUR
| Q1 26 | — | — | ||
| Q4 25 | 49.6% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 47.8% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
资本支出强度DOCMUR
| Q1 26 | 3.4% | — | ||
| Q4 25 | 124.4% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 105.6% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金转化率DOCMUR
| Q1 26 | — | — | ||
| Q4 25 | 10.99× | 20.92× | ||
| Q3 25 | — | — | ||
| Q2 25 | 11.48× | 16.06× | ||
| Q1 25 | 6.52× | 4.12× | ||
| Q4 24 | 235.43× | 8.61× | ||
| Q3 24 | 3.71× | 3.08× | ||
| Q2 24 | 2.17× | 3.66× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOC
| Outpatient Medical | $320.5M | 46% |
| Lab | $217.6M | 31% |
| Senior Housing | $148.9M | 21% |
| Other | $14.3M | 2% |
| Corporate Non-segment | $1.5M | 0% |
MUR
暂无分部数据
